Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Gynecol Oncol. 2008 Mar 7;109(2):263–269. doi: 10.1016/j.ygyno.2008.01.024

Table 2.

Rate of claudin-3 and claudin-4 expression (absent/weak vs. high) and disease characteristics including type of histology, FIGO stage, and grade.

Patients Claudin-3 Positive IHC Claudin-4 Positive IHC
No. Valid % No. Valid % No. Valid %
Histology*
    Endometrioid grade 1 52 (18) 19/48 (40) 1/47 (2)
    Endometrioid grade 2 58 (20) 20/54 (37) 4/51 (7)
    Endometrioid grade 3 40 (14) 14/36 (39) 7/31 (18)
        Clear cell 25 (9) 14/23 (61) 10/23 (44)
    Serous papillary 112 (39) 69/89 (78) 49/88 (56)
FIGO Stage**
                I 146 (51) 55/123 (45) 21/125 (17)
                II 9 (3) 4/8 (50) 0/8 (0)
                III 52 (18) 26/48 (54) 14/49 (29)
                IV 80 (28) 51/71 (72) 36/69 (52)
Grade***
                1 55 (20) 20/50 (40) 2/50 (4)
                2 62 (23) 23/58 (40) 5/59 (9)
                3 153 (57) 81/128 (63) 56/128 (44)

Unknown data: grade (n = 17), claudin-3 (n = 37), claudin-4 (n = 36).

*

Chi square test: P < 0.001 for both Claudin-3 and Claudin-4.

**

Chi square test: P = 0.004 for Claudin-3, and P < 0.001 for Claudin-4.

***

Chi square test: P = 0.002 for Claudin-3, and P < 0.001 for Claudin-4.